Literature DB >> 23026560

Facilitating pharmacometric workflow with the metrumrg package for R.

Timothy T Bergsma1, William Knebel, Jeannine Fisher, William R Gillespie, Matthew M Riggs, Leonid Gibiansky, Marc R Gastonguay.   

Abstract

metrumrg is an R package that facilitates workflow for the discipline of pharmacometrics. Support is provided for data preparation, modeling, simulation, diagnostics, and reporting. Existing tools and techniques are emphasized where available; original solutions are provided for otherwise unmet needs. In particular, metrumrg implements an R interface for the NONMEM(®) modeling software, optionally run in a distributed computing environment. The paradigm allows start-to-finish analyses in a single scripting language. Emphasis on text-based formats promotes traceability of results.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 23026560     DOI: 10.1016/j.cmpb.2012.08.009

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  7 in total

1.  Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study.

Authors:  Athena F Zuppa; Daniela J Conrado; Nicole R Zane; Martha A Q Curley; Jonathan Bradfield; Hakon Hakonarson; Madeleine S Gastonguay; Ganesh Moorthy; Janice Prodell; Marc R Gastonguay
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 2.  Enhancing population pharmacokinetic modeling efficiency and quality using an integrated workflow.

Authors:  Henning Schmidt; Andrijana Radivojevic
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-07-24       Impact factor: 2.745

3.  Determination of appropriate weight-based cutoffs for empiric cefazolin dosing using data from a phase 1 pharmacokinetics and safety study of cefazolin administered for surgical prophylaxis in pediatric patients aged 10 to 12 years.

Authors:  Michael L Schmitz; Jeffrey L Blumer; Wes Cetnarowski; Christopher M Rubino
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

4.  Clinical Trial Simulations and Pharmacometric Analysis in Pediatrics: Application to Inhaled Loxapine in Children and Adolescents.

Authors:  Min Dong; Tsuyoshi Fukuda; Sally Selim; Mark A Smith; Laura Rabinovich-Guilatt; James V Cassella; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

5.  Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.

Authors:  Carrie A Morris; Beesan Tan; Stephan Duparc; Isabelle Borghini-Fuhrer; Donald Jung; Chang-Sik Shin; Lawrence Fleckenstein
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model-Informed Drug Discovery and Development.

Authors:  J J Wilkins; Pls Chan; J Chard; G Smith; M K Smith; M Beer; A Dunn; C Flandorfer; C Franklin; R Gomeni; L Harnisch; R Kaye; S Moodie; M L Sardu; E Wang; E Watson; K Wolstencroft; Sya Cheung
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-05-15

7.  Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia.

Authors:  Mita Kuchimanchi; Anita Grover; Maurice G Emery; Ransi Somaratne; Scott M Wasserman; John P Gibbs; Sameer Doshi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-05-07       Impact factor: 2.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.